2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA
Announces Commencement of an Offer to Purchase Outstanding Warrants
Amended material disclosure
Jasper Therapeutics, Inc. Special Meeting Results - Proposals Approved
CFO Resignation - Herb Cross Steps Down; Jeet Mahal Named Interim CFO
Notice of Delisting - Jasper Therapeutics, Inc. Fails to Meet Nasdaq Equity R...
Shareholder votes
Other Events
Q2
Q1
FY 2025
Q3
FY 2023
SC TO-I
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Notification Filed by a National Security Exchange
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload
S-8 POS